The Latest Breaking News from Johnson & Johnson (

Our senior market strategist takes a look at traditionally defensive sectors to find opportunities in the current market uncertainty.

No stock is completely safe, but we can make educated guesses about which ones are likely to provide smooth sailing.

Exasperation over lengthy wait for women to be compensated for pelvic mesh implant injuries has led to promises that money will start flowing soon.

Resilient stocks and ETFs offering steady demand and dividend yields may help investors weather further market turbulence without abandoning equity exposure.

Johnson & Johnson (JNJ) has a diversified business model that makes it resilient through economic cycles. JNJ is trading at new all-time highs. The stock maintains a 100% “Buy” technical opinion from Barchart. Analyst sentiment is mixed. JNJ has many “Strong Buy” opinions, but some analysts consider JNJ overvalued. Today’s...

Although Johnson & Johnson has outpaced the broader market over the past year, Wall Street analysts maintain a cautiously optimistic outlook on the stock’s prospects.

In uncertain markets, reliable income matters more than ever. This Dividend King offers exactly that.

Johnson & Johnson is poised to advance in H2 2026 as growth, cash flow, and capital returns drive bullish analysts and institutional sentiment.

Markets enter a holiday-shortened week with the Martin Luther King, Jr. Day closure Monday, followed by a convergence of events including President Trump's inauguration speech Wednesday at 8:30am